NCT04691323View on ClinicalTrials.gov

The Longitudinal Relationship of HU Adherence to HRQOL, Barriers to Adherence and Habit in SCD.

NAActive, not recruitingINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

March 2, 2021

Primary Completion Date

June 1, 2025

Study Completion Date

December 1, 2025

Conditions
Sickle Cell DiseaseSickle B+ ThalassemiaSickle Beta Zero ThalassemiaSickle Cell Hemoglobin C
Interventions
OTHER

HU-Go app

A novel multifunctional mobile app (HU-Go) to improve adherence to hydroxyurea in patients with sickle cell disease

Trial Locations (1)

60611

Ann & Robert H Lurie Children's Hospital of Chicago, Chicago

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Ann & Robert H Lurie Children's Hospital of Chicago

OTHER